Scientists have discovered genetic variations in the inflammation pathway that reduce the likelihood of recurrence and increase survival of patients with non-muscle invasive bladder cancer who are treated with mainstream therapy.
Full article >>
Thursday, April 23, 2009
Genetic Variants Predict Recurrence Of Bladder Cancer, Patient Survival
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment